Patents by Inventor Marshall Dunlop

Marshall Dunlop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20230406933
    Abstract: The present invention relates to therapeutic antibodies, or antigen-binding portions thereof, for use in the treatment of cancer and infectious disease. Specifically, the present invention relates to therapeutic antibodies, or antigen-binding portions thereof, that target the programmed death-ligand 1 polypeptide. The present invention also relates to pharmaceutical compositions comprising said therapeutic antibody, or antigen-binding portions thereof.
    Type: Application
    Filed: November 2, 2021
    Publication date: December 21, 2023
    Inventors: Marshall Dunlop, Shirley Schon, John Lamont, Peter Fitzgerald
  • Antibody Libraries
    Publication number: 20080206780
    Abstract: The invention relates to a composition comprising a plurality of antibody fragments, each comprising a framework region having a murine VH14 heavy chain and a murine VK2 light chain, or homologues thereof, each antibody fragment further comprising at least one different CDR.
    Type: Application
    Filed: September 19, 2005
    Publication date: August 28, 2008
    Applicant: Randox Laboratories Ltd.
    Inventors: Peter Fitzgerald, John Lamont, Marshall Dunlop, Shirley Schon